Anti–Phospholipase A2 Receptor 1 and Anti–Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study-Reference-Cited by-同舟云学术

Anti–Phospholipase A2 Receptor 1 and Anti–Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study

Published:2023-12 Issue: Volume: Page:
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Ruggenenti Piero,Reinhard Linda,Ruggiero Barbara,Perna Annalisa,Perico Luca,Peracchi Tobia,Fidone Diego,Gennarini Alessia,Benigni Ariela,Cortinovis Monica,Hoxha Elion,Remuzzi Giuseppe

Funder

Deutsche Forschungsgemeinschaft

Publisher

Elsevier BV

Subject

Nephrology

Reference44 articles.

1. Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997;Haas;Am J Kidney Dis,1997

2. Treatment of membranous nephropathy: time for a paradigm shift;Ruggenenti;Nat Rev Nephrol,2017

3. Membranous nephropathy: new pathogenic mechanisms and their clinical implications;Hoxha;Nat Rev Nephrol,2022

4. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy;Beck;N Engl J Med,2009

5. Prognosis of untreated patients with idiopathic membranous nephropathy;Schieppati;N Engl J Med,1993

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantity Versus Quality of Anti–Phospholipase A2 Receptor 1 Autoantibodies in the Assessment of Clinical Outcome in Membranous Nephropathy: The Debate Continues;American Journal of Kidney Diseases;2024-05

2. Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases;Frontiers in Immunology;2024-02-26